MacroGenics to Participate in Upcoming Investor Conference

Rhea-AI Summary

MacroGenics, Inc. (MGNX) to participate in the 42nd Annual J.P. Morgan Healthcare Conference with President & CEO, Scott Koenig, M.D., Ph.D., providing a corporate overview on January 11, 2024.

ROCKVILLE, MD, Jan. 08, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following upcoming investor conference:

• 42nd Annual J.P. Morgan Healthcare Conference. MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., Ph.D., will provide a corporate overview on Thursday, January 11, 2024, at 7:30 am PT. Management will also participate in one-on-one meetings.

A webcast of the above presentation may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm. The Company will maintain an archived replay of this webcast on its website for 30 days after the conference.

About MacroGenics, Inc.
MacroGenics (the Company) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company's website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.

###

FAQ

What is the upcoming investor conference MacroGenics, Inc. (MGNX) will participate in?

MacroGenics, Inc. (MGNX) will participate in the 42nd Annual J.P. Morgan Healthcare Conference.

Who will provide a corporate overview at the conference for MacroGenics, Inc. (MGNX)?

The President & CEO, Scott Koenig, M.D., Ph.D., will provide a corporate overview.

When will the corporate overview be provided at the conference for MacroGenics, Inc. (MGNX)?

The corporate overview will be provided on Thursday, January 11, 2024, at 7:30 am PT.

Where can the webcast of the presentation be accessed for MacroGenics, Inc. (MGNX)?

The webcast of the presentation may be accessed under 'Events & Presentations' in the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm.

How long will the archived replay of the webcast be available for MacroGenics, Inc. (MGNX)?

The archived replay of the webcast will be available on its website for 30 days after the conference.